Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation For Tralesinidase Alfa Enzyme Replacement Therapy In Sanfilippo Syndrome Type B (MPS IIIB)

Tradingkey - Geopolitical tensions escalated sharply over the weekend. Following the conclusion of Trump's visit to China, tensions between the U.S. and Iran flared up once again. Renewed expectations of a long-term blockade of the Strait of Hormuz pushed both major crude oil futures to nearly two-week highs. As of press time, Brent crude broke above the $110 mark, rising 1.80% to $111.45 per barrel, having touched its highest level since May 5 during intraday trading. WTI crude oil futures rose 2.39% to $103.41 per barrel.

TradingKey - In the early Asian session on May 18, gold prices (XAUUSD) extended last week's downward trend, falling for the fifth consecutive trading day. Prices briefly broke below $4,500 intraday, hitting a low of $4,480.54. Gold is currently trading at $4,497.11, down approximately 1% from last Friday.

TradingKey - Nvidia Q1 FY2027 earnings May 20. Consensus: $78B revenue, $65B+ data centre, 74%+ margins. BofA target $320. NVDA at $224 at Fib 0.382 support. Breakout targets $231–$237.

TradingKey — According to a report by WIRED, OpenAI recently announced a corporate restructuring to consolidate its product lines. Its three core product offerings—ChatGPT, Codex, and the API—are being dismantled and merged into a unified product organization to "embrace" the Agentic Future; co-foun

TradingKey - Last Friday (May 15), The Wall Street Journal reported, citing people familiar with the matter, that Elon Musk’s SpaceX plans to officially list on the Nasdaq on June 12 under the ticker symbol “SPCX,” with an expected fundraising target of $80 billion or more. If successful, this would